Quick Order Cart

Cat. No. ARG1166

NDEL1 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

NDEL1 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the human B lymphoblastoid Raji cell line. This loss-of-function model targets NDEL1, a scaffold protein essential for dynein motor complex regulation, microtubule organization, and centrosome positioning, enabling investigation of dynein-mediated transport and mitotic spindle assembly in immune cells. The Raji background, an EBV-transformed line widely used in immunological studies, provides a relevant context for examining NDEL1??s roles in lymphocyte function. Key interacting partners include LIS1 (PAFAH1B1) and the dynein-dynactin complex, with phosphorylation by CDK5 and Aurora A modulating activity. This product supports research into cytoskeletal dynamics, neurodevelopmental disorders, and cancer biology through techniques such as immunofluorescence microscopy, co-immunoprecipitation, and phospho-specific signaling analysis.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    NDEL1

    Gene Identifier

    NCBI Gene ID 81565

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% COâ‚‚

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The NDEL1 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the human B lymphoblastoid Raji cell line. This loss-of-function model disrupts NDEL1, a scaffold protein crucial for dynein motor regulation and microtubule organization. The polyclonal format provides a heterogeneous pool of edited cells, minimizing clonal selection bias.

Raji is an EBV-transformed B lymphoblastoid line from a Burkitt lymphoma patient, widely used in immunology for antibody production, antigen presentation, and B-cell biology studies. Its stable karyotype and amenability to diverse assays make it an effective host for studying gene function in immune cells.

NDEL1 functions as a scaffold protein that couples the dynein motor complex to microtubules and cellular cargoes, thereby regulating neuronal migration, mitotic spindle orientation, and centrosome positioning. It acts downstream of the Reelin signaling pathway: Reelin binding to ApoER2/VLDLR receptors activates Dab1 and Src family kinases, leading to NDEL1 phosphorylation. Phosphorylation by CDK5 and Aurora A kinase modulates NDEL1??s interaction with LIS1 (PAFAH1B1) and the dynein-dynactin motor complex, influencing dynein activity, microtubule dynamics, and nuclear envelope positioning during mitosis. Additional interacting proteins include DISC1, 14-3-3, and the microtubule-severing enzyme katanin, placing NDEL1 at a hub of pathways associated with neurodevelopmental and psychiatric disorders.

In the Raji lymphocyte context, NDEL1 disruption provides a system to dissect its functions in immune cell biology, particularly in processes requiring microtubule-dependent transport, cell division, and antigen presentation. While NDEL1 is primarily studied in neurons, its expression in B cells implies conserved roles in mitotic spindle assembly and dynein-mediated organelle trafficking. Knockout in Raji cells may uncover phenotypes in proliferation, cytokine secretion, or immune synapse formation, and offers a platform to explore connections between NDEL1 signaling and lymphomagenesis.

Applications include immunofluorescence microscopy to visualize microtubule organization and centrosome positioning, flow cytometry for cell cycle profiling, and Western blotting to assess NDEL1 loss and pathway compensation. Co-immunoprecipitation with LIS1 or dynein intermediate chain and phospho-specific antibodies enable dissection of CDK5- and Aurora A-dependent signaling. Live-cell imaging and motility assays facilitate analysis of dynein-driven transport. This model is relevant for schizophrenia and lissencephaly research by studying conserved neuronal pathways in a tractable cell system, and for cancer biology investigating mitotic vulnerabilities. The polyclonal format is advantageous for pooled CRISPR screening and phenotypic characterization without clonal artifacts. For more information, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)